A multicenter prospective observational study of atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP) in patients with unresectable advanced or relapsed EGFR-mutation positive nonsquamous non-small-cell lung cancer: ABCP observational study
Not Applicable
- Conditions
- non-small-cell lung cancer
- Registration Number
- JPRN-UMIN000037967
- Lead Sponsor
- Department of Thoracic Oncology, Kansai Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 142
Inclusion Criteria
Not provided
Exclusion Criteria
A Patient who is judged ineligible to enroll the study by an attending doctor.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method